Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction.
暂无分享,去创建一个
V. Cameron | A. Richards | S. Medicherla | A. Protter | T. Yandle | A. Pilbrow | P. Bridgman | L. Ellmers | N. J. Scott | Nicola J A Scott | Nicola J. A. Scott | Vicky A. Cameron | A. Richards | Andrew A. Protter | Leigh. J. Ellmers | Paul G. Bridgman
[1] P. Sehgal,et al. Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension. , 2008, American journal of respiratory and critical care medicine.
[2] Gerard C Blobe,et al. Role of transforming growth factor-beta superfamily signaling pathways in human disease. , 2008, Biochimica et biophysica acta.
[3] Jinmai Jiang,et al. TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[4] N. Frangogiannis,et al. The role of TGF-β Signaling in Myocardial Infarction and Cardiac Remodeling , 2007 .
[5] J. Mehta,et al. The TGFβ superfamily in cardiovascular biology , 2007 .
[6] V. Cameron,et al. Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. , 2007, Journal of molecular endocrinology.
[7] S. Ledbetter,et al. Neutralization of transforming growth factor-β attenuates hypertension and prevents renal injury in uremic rats , 2005, Journal of hypertension.
[8] G. Takemura,et al. Postinfarction Gene Therapy Against Transforming Growth Factor-β Signal Modulates Infarct Tissue Dynamics and Attenuates Left Ventricular Remodeling and Heart Failure , 2005 .
[9] M. Kolb,et al. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. , 2005, American journal of respiratory and critical care medicine.
[10] S. Rosenkranz. TGF-β1 and angiotensin networking in cardiac remodeling , 2004 .
[11] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[12] G. Shen,et al. Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosclerotic rabbits. , 2003, Atherosclerosis.
[13] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[14] S. Ledbetter,et al. Antihypertensive effects of chronic anti-TGF-β antibody therapy in Dahl S rats , 2002 .
[15] S. Rosenkranz,et al. Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1 , 2002 .
[16] M. Goumans,et al. Transforming growth factor β signal transduction , 2002, Journal of leukocyte biology.
[17] T. Doetschman,et al. TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II , 2002 .
[18] J. Cohn,et al. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. , 2001, The New England journal of medicine.
[19] C. Lau,et al. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. , 2001, Journal of the American College of Cardiology.
[20] A. Deten,et al. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. , 2001, Journal of molecular and cellular cardiology.
[21] Shokei Kim,et al. Effects of Combination of ACE Inhibitor and Angiotensin Receptor Blocker on Cardiac Remodeling, Cardiac Function, and Survival in Rat Heart Failure , 2001, Circulation.
[22] V. Petrov,et al. Induction of cardiac fibrosis by transforming growth factor-beta(1). , 2000, Molecular genetics and metabolism.
[23] K. Weber,et al. Connective tissue and the heart. Functional significance and regulatory mechanisms. , 2000, Cardiology clinics.
[24] W A Hsueh,et al. Angiotensin II, adhesion, and cardiac fibrosis. , 2000, Cardiovascular research.
[25] Paul A. Overbeek,et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice , 2000, Nature Medicine.
[26] Y. Sun,et al. Cardiac remodeling by fibrous tissue after infarction in rats. , 2000, The Journal of laboratory and clinical medicine.
[27] L. Field,et al. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. , 2000, Circulation research.
[28] Y. Yazaki,et al. Role of the renin-angiotensin system in cardiac hypertrophy. , 1999, The American journal of cardiology.
[29] I. Dixon,et al. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. , 1999, Journal of molecular and cellular cardiology.
[30] L. Katwa,et al. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. , 1997, Journal of molecular and cellular cardiology.
[31] Shokei Kim,et al. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats , 1996, British journal of pharmacology.
[32] N. Morisaki,et al. In Vivo Effect of TGF-β1 , 1995 .
[33] A. McCulloch,et al. Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts , 1995 .
[34] Meihong Lin,et al. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. , 1995, The Journal of clinical investigation.
[35] N. Takahashi,et al. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes. , 1994, The Journal of clinical investigation.
[36] P. Dunn,et al. Outpatient screening tests for primary aldosteronism. , 1976, Australian and New Zealand journal of medicine.
[37] Shokei Kim,et al. Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. , 2003, Cardiovascular research.
[38] J. Massagué,et al. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.
[39] V. Lindner. Vascular repair processes mediated by transforming growth factor-β , 2001, Zeitschrift für Kardiologie.
[40] B. Swynghedauw,et al. Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.
[41] Y. Sun,et al. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. , 1998, Journal of molecular and cellular cardiology.
[42] N. Morisaki,et al. In vivo effect of TGF- beta 1. Enhanced intimal thickening by administration of TGF- beta 1 in rabbit arteries injured with a balloon catheter. , 1995, Arteriosclerosis, thrombosis, and vascular biology.